Drug Profile
Lung cancer DNA vaccine - Immune Cell Therapy
Alternative Names: IC-1001; IC-1001 personalised lung cancer vaccine; IC-1001 personalized lung cancer vaccineLatest Information Update: 04 Apr 2016
Price :
$50
*
At a glance
- Originator Immune Cell Therapy
- Class Cancer vaccines; DNA vaccines; Gene therapies
- Mechanism of Action Gene transference; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Non-small cell lung cancer
Most Recent Events
- 04 Apr 2016 No development reported - Phase-I for Non-small cell lung cancer in USA (Intradermal)
- 31 Jan 2012 Phase-I clinical trials in Non-small cell lung cancer in USA (Intradermal)